Ironwood Pharmaceuticals, Inc.
IRWD
$0.7267
-$0.0233-3.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 307.54% | -76.20% | 99.92% | -109.10% | -102.22% |
| Total Depreciation and Amortization | -5.27% | 78.90% | -60.74% | 79.37% | 50.59% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.52% | -25.32% | -97.89% | -38.71% | 61.47% |
| Change in Net Operating Assets | -293.35% | -124.04% | -23.78% | 249.58% | -500.23% |
| Cash from Operations | -57.54% | -69.55% | -4.28% | -43.89% | -54.74% |
| Capital Expenditure | 100.00% | 67.35% | -- | -423.08% | -881.48% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 100.00% | 99.93% | 99.99% | -423.08% | -15,611.11% |
| Total Debt Issued | -- | -- | -62.50% | -- | -- |
| Total Debt Repaid | 40.00% | 66.67% | -- | -- | -- |
| Issuance of Common Stock | -79.66% | -100.00% | -45.17% | 152.73% | -64.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 99.67% | -- | -- | -- | -- |
| Cash from Financing | 70.75% | 63.79% | -112.37% | -490.73% | -1,914.11% |
| Foreign Exchange rate Adjustments | 142.00% | -766.67% | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 101.80% | 73.43% | 97.17% | -65.07% | -123.54% |